InsidersTradesSigma
Explore the detailed record of transactions filed by Olinger Margaret, Directeur commercial. Insider active across 1 companies, notably Amylyx Pharmaceuticals, Inc.. Cumulatively, 2 disclosures have been published. The latest transaction was disclosed on 6 January 2022 (Attribution). Regulator: SEC (Form 4). The full history is free.
2 of 2 declarations
Margaret Olinger is the Chief Commercial Officer at Amylyx Pharmaceuticals, Inc. She is responsible for commercial strategy and business development, aiming to maximize the company's growth and market impact. Her expertise in marketing and sales is crucial for achieving business objectives.